Cargando…
Effect of PCSK9 Inhibitor on Contrast-Induced Acute Kidney Injury in Patients with Acute Myocardial Infarction Undergoing Intervention Therapy
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have been shown to inhibit pyroptosis and apoptosis, which play important roles in the development and progression of contrast-induced acute kidney injury (CI-AKI). However, to the best of our knowledge, no studies have investigated th...
Autores principales: | Ma, Yu, Zha, Lei, Zhang, Qi, Cao, Lu, Zhao, Ru, Ma, Jing, Hou, Kai, Pan, Yue, Cong, Hongliang, Li, Ximing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427281/ https://www.ncbi.nlm.nih.gov/pubmed/36051574 http://dx.doi.org/10.1155/2022/1638209 |
Ejemplares similares
-
Role of serum CAP1 protein in the diagnosis of patients with first-time acute myocardial infarction
por: Jin, Dongxia, et al.
Publicado: (2023) -
Sex Differences Associated With Circulating PCSK9 in Patients Presenting With Acute Myocardial Infarction
por: Zhang, Zhong, et al.
Publicado: (2019) -
In-hospital initiation of PCSK9 inhibitor and short-term lipid control in patients with acute myocardial infarction
por: Lou, Bowen, et al.
Publicado: (2022) -
Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes
por: Li, Tingting, et al.
Publicado: (2021) -
Plasma PCSK9 Levels Are Elevated with Acute Myocardial Infarction in Two Independent Retrospective Angiographic Studies
por: Almontashiri, Naif A. M., et al.
Publicado: (2014)